About David B Ross, MD
Dr. David B. Ross, MD, the creator of the NP3, is a leading expert in neuropathy and pain management. He graduated from Johns Hopkins University and the University of Miami School of Medicine. He completed post-doctoral training in Internal Medicine at the University of Miami; and his residency in Neurology at Harvard Medical School where he was a Chief Resident – Neurology from 1982 to 1983. He is Board Certified as a member of the American Academy of Psychiatry and Neurology.
Dr. Ross completed independent research with Saul Roseman, PhD, Chairman of Biology, Johns Hopkins University Medical Center and with Karl Sandhoff, PhD of the Max Planck Institute. He served as a faculty member for the University of Miami before beginning private practice, and he is a published expert in the area of neuropathy.
Dr. Ross is a member of the American Medical Association, the American Academy of Neurology, the New York Academy of Science and the American Association for the Advancement of Science. Dr. Ross has participated in numerous basic science research projects; and has received numerous research grants and investigator awards.
He has served as an expert witness in litigation matters, as a neurological expert in chronic pain, and has given many presentations on a variety of medical subjects.
- Hackman JC, Ross DB and Davidoff RA. (1978): Some actions of Catechol on synaotic transmission in the isolated spinal cord of the frog. Brain Research 157:47-61.
- Valdes-Dapena MA, Amazon KA, Gillane MM. Ross DB and Catherman R (1980): The question of the right ventricular hypertrophy in Sudden Infant Death Syndrome. Arch Pathol Lab Med103: 184-186.
- Valdes-Dapena MA, Gillane MM, Ross DB and Catherman R (1979): Extramedullary hematopoiesis in the liver in Sudden Infant Death Syndrome. Arch Pathol Lab Med 103: 513-515.
- Valdes-Dapena MA, Gillane MM, Cassady JC, Ross DB and Catherman R (1980): Wall thickness of small pulmonary arteries. Its measurement in victims of Sudden Infant Death Syndrme. Arch Pathol Lab Med 104: 621-624.
- Berger JB and Ross DB (1981): Reversible Parkinson’s syndrome complicating post operative hypoparathyroidism. Neurology 31: 881-883.
- Sotrel A, Rosen S, Ross DB and Ronthal M (1983): Subacute sclerosing Panencephalitis: “an immune complex disease”? Neurology 33: 885-887.
- Ross DB, Fischer J, Konkol S and Jones HR (1983): Isolated radial nerve palsy in the newborn. Neurology33: 1354-1355.
- Ross DB, Varipapa RJ (1989): Treatment of Painful Diabetic Neuropathy with topical capsaicin. New England Journal of Medicine 321: 474-475.
- Chad DA, Aronin N, Ross DB, and et.al, (1990): “(Does capsaicin relieve the pain of diabetic neuropathy?)” Pain 42: 387-388.
- Pfeifer M, Jung RN, Ross DB. Et.al. (1993): A Highly Successful Model for the treatment of Painful Diabetic Neuropathy. Diabetic Research.
- Ross DB. A Primer on the Interpretation of Neurodiagnostic Studies (in preparation).
- Ross DB. “Peripheral Neuropathy – A Common Medical Entity.” Positive Voices. Volume 4, Issue 1. (1999).
- Grand Rounds: Facial dysmorphism in the evaluation of Infantile Seizures. Harvard Medical School, 1983.
- Grand Rounds: Differential diagnosis of dementia associated with abnormal eye movements. University of Miami School of Medicine. 1983.
- Lecture: New Advances in the diagnosis of dementia. National Neuroscience Congress of Argentine (“SemcosinII”), Guest lecturer 1986.
- Lecture: Electrodiagosis of radiculopathy. National Neuroscience Congress of Argentine (“Semcosin II”), Guest lecturer 1986.
- Lecture (with Gustavo Roman, M.D.): Advances in the treatment of Parkinson’s disease. National Neuroscience Congress of Argentine (“Semcosin II”), Guest Lecturer 1986.
- Lecture: Clinical model for treatment of painful peripheral diabetic Neuropathy. American Canadian Pain Society Annual Meeting, 1988.
- Lecture: A clinical model for the treatment of chronic pain. University of Louisville Medical Center, 1989.
- Lecture: Treatment of chronic pain. University of Louisville Affiliated Hospitals, 1990.
- Lecture: Trigger point therapy as part of a total approach to the Management of chronic pain. University of Louisville Veteran’s Administration Hospital, 1991.
- Lecture: Myofacial pain syndrome in the post-operative pain after hand Surgery. University of Louisville Affiliated Hospitals, 1992.
- Moderator: Natonal Teleconference. New advances in the treatment of Multiple sclerosis. Hollywood, Florida, 1993.
- Moderator: International Teleconference. The role of Felbatol in the Management of refratory seizures. San Juan, Puerto Rico, 1993.
- Lecture: The uses and abuses of neurodiagnostic testing. State Farm Insurance Company, Fort Lauderdale, Florida, 1995.
- Lectures: The use of Aricept in the treatment of Alzheimer’s disease.
- Speaker for Pfizer Pharmaceutical Company. 1997-1998.
- Lecture. The diagnosis and treatment of Alzheimer’s disease. The West Broward Alzheimer’s Support Group, 1997.
- Lecture. The use of Maxalt n the treatment of migraine headaches.
- Speaker for Merck Pharmaceutical Company, 1999.
- Lecture. Advances in the Treatment of Stroke-Brain Attack. Speaker for Plantation General Hospital. 2000.
- TV appearance. Advances in the Treatment of Stroke-Brain Attack.
- Speaker for Plantation General Hospital. 2000.
- Radio talk. Advances in the Headache. Speaker for Hollywood Medical 2000.
- Lecture. Treatment of Dementia. Speaker for Janssen Pharmaceutical Company, Destin, Florida. 2001.
- Speaker on pain conditions and a new Interventional Pain Assessment Tool at the IASP ( International Association for the Study of Pain) conference Tennessee, USA. 2009.
- Presentation on a new Interventional Pain Assessment Tool at Johns Hopkins University Baltimore, Maryland. 2010.
- Presentation on a new Interventional Pain Assessment Tool at the Mayo Clinic Rochester, Minnesota. 2010.
- Presentation on a new Interventional Pain Assessment Tool at Harvard University 2010.
- Presentation on a new Interventional Pain Assessment Tool at Dalhousie University Halifax, Nova Scotia. 2010.
- Presentation on “Changing Concepts of Pain: Increasing the Role of the Behavioral Health Professional” at the Mental Health Association of Southeast Florida. 2013
SpineUniverse, a Vertical Health, LLC website, is committed to ensuring that the medical information it presents is accurate, balanced, objective, and trustworthy.
To help achieve this goal, SpineUniverse requires all authors, editors, and reviewers to disclose any financial relationships or affiliations they have with companies whose products or services may be mentioned in the content they author, edit, or review.
The intent of this policy is to identify any perceived, potential, or real conflicts of interest so that readers can make their own judgments about the value of information being presented.